Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SILK
3051
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $493K | ﹤0.01% |
10,295
-17,040
| -62% | -$868K |
|
|
MODN
3052
DELISTED
MODEL N, INC.
MODN
| $490K | ﹤0.01% |
14,321
-21,645
| -60% | -$794K |
|
3053
Biglari Holdings Class B
BH
$1.23B
| $489K | ﹤0.01% |
3,068
-1,207
| -28% | -$186K |
|
|
GDEN
3054
DELISTED
Golden Entertainment
GDEN
| $488K | ﹤0.01% |
10,896
-21,718
| -67% | -$830K |
|
3055
Oramed Pharmaceuticals
ORMP
$183M
| $488K | ﹤0.01% |
36,481
+15,998
| +78% | +$183K |
|
|
INFN
3056
DELISTED
Infinera Corporation Common Stock
INFN
| $488K | ﹤0.01% |
47,846
-90,307
| -65% | -$876K |
|
|
XENT
3057
DELISTED
Intersect ENT, Inc
XENT
| $487K | ﹤0.01% |
28,534
-164,171
| -85% | -$3.07M |
|
3058
Marcus Corp
MCS
$959M
| $486K | ﹤0.01% |
22,925
-7,539
| -25% | -$157K |
|
3059
Kodiak Sciences
KOD
$2.68B
| $484K | ﹤0.01% |
5,192
-45,032
| -90% | -$4.32M |
|
3060
Rayonier Advanced Materials
RYAM
$591M
| $484K | ﹤0.01% |
72,478
-5,388
| -7% | -$43.9K |
|
|
KBAL
3061
DELISTED
Kimball International
KBAL
| $483K | ﹤0.01% |
36,679
-28,238
| -43% | -$385K |
|
3062
Prospect Capital
PSEC
$1.13B
| $481K | ﹤0.01% |
57,246
+41,620
| +266% | +$348K |
|
3063
Ultrapar
UGP
$6.75B
| $480K | ﹤0.01% |
+127,590
| New | +$494K |
|
|
RC
3064
Ready Capital
RC
$287M
| $479K | ﹤0.01% |
30,209
-42,608
| -59% | -$631K |
|
3065
OraSure Technologies
OSUR
$287M
| $478K | ﹤0.01% |
47,200
-48,389
| -51% | -$471K |
|
3066
PUT
ProShares Ultra S&P500
SSO
$8.32B
| $477K | ﹤0.01% |
16,000
| – | – |
|
3067
MBIA
MBI
$268M
| $476K | ﹤0.01% |
43,281
-43,624
| -50% | -$435K |
|
|
HNP
3068
DELISTED
Huaneng Power Intl, Inc.
HNP
| $476K | ﹤0.01% |
+30,000
| New | +$439K |
|
3069
CALL
Kroger
KR
$35.4B
| $475K | ﹤0.01% |
12,400
-61,100
| -83% | -$2.3M |
|
3070
Byline Bancorp
BY
$1.81B
| $472K | ﹤0.01% |
20,840
-10,583
| -34% | -$237K |
|
3071
MGP Ingredients
MGPI
$366M
| $471K | ﹤0.01% |
6,970
-24,144
| -78% | -$1.58M |
|
3072
VanEck Intermediate Muni ETF
ITM
$2.14B
| $470K | ﹤0.01% |
+9,067
| New | +$469K |
|
|
SCHR
3073
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $470K | ﹤0.01% |
+16,518
| New | +$469K |
|
|
APTS
3074
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $470K | ﹤0.01% |
48,119
-32,552
| -40% | -$330K |
|
|
BDSI
3075
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $470K | ﹤0.01% |
131,596
-62,201
| -32% | -$219K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.